MetLife Investment Advisors »

Cytokinetics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.1M 49k 83.49
2023-09-30 $1.4M 49k 29.46
2023-06-30 $1.6M 49k 32.62
2023-03-31 $1.5M 43k 35.19
2022-12-31 $2.0M 43k 45.82
2022-09-30 $2.1M 43k 48.44
2022-06-30 $1.7M 43k 39.28
2022-03-31 $1.6M 43k 36.81
2021-12-31 $1.3M 29k 45.58
2021-09-30 $1.0M 29k 35.74
2021-06-30 $504k 26k 19.79
2021-03-31 $593k 26k 23.26
2020-12-31 $591k 29k 20.77
2020-09-30 $616k 29k 21.65
2020-06-30 $621k 26k 23.57
2020-03-31 $311k 26k 11.80
2019-12-31 $280k 26k 10.63
2019-09-30 $300k 26k 11.39
2019-06-30 $296k 26k 11.25
2019-03-31 $151k 19k 8.07
2018-12-31 $118k 19k 6.30
2018-09-30 $291k 30k 9.85
2018-06-30 $155k 19k 8.28
2018-03-31 $135k 19k 7.21
2017-12-31 $153k 19k 8.17